According to the International Diabetes Foundation’s figures, more than 380 million people around the world are coping with a diabetes diagnosis. That’s a lot of people that must alter their way of living and use Diabetes (type 1) testing supplies. However, if the researchers at the Harvard School of Public Health are correct, that number may drop in the future.
In December 2013, researchers connected with the school’s Hotamisligil Laboratory released the results of a study that revealed a potential way to prevent the disease from occurring. The potential solution to the longstanding disease rests with our endoplasmic reticulum (ER). For those that are unfamiliar with ER, it is an organelle found in some human cells. There are two types. They are referred to as rough and smooth. The rough one aids in protein synthesis. In those with type 1 diabetes, those cells are not functioning properly.
What researchers discovered is that there is an amphiphilic bile acid that has the capability of offsetting that dysfunction in laboratory mice. As a result of that offsetting, the onset of diabetes(Type 1) may effectively be delayed or stopped altogether. Of course, additional research and diabetes testing(type 1) must be conducted in the coming years to determine whether or not the same results may be possible to obtain in humans.
Until then, those living with the disease must continue with their type 1 diabetes testing regimens and insulin injections to ensure their quality of life. At this time, failure to properly manage the disease often results in the development of assorted comorbidities. Those comorbidities include vision loss, kidney failure, strokes, heart attacks, and blood vessel disease.
Recent Guideline Changes May Help To Reduce Gestational Diabetes Risk
A study related to gestational diabetes (Risks of Gestational Diabetes) appeared in The Endocrine Society’s publication, the Journal of Clinical Endocrinology and Metabolism. It was titled Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline. Upon its release, obstetricians undoubtedly started to question how they’ve been treating diabetic and pre-diabetic pregnant women for years.
The study was actually designed to come up with best practices that physicians could use to treat diabetic women of child bearing age. It looked at pregnant women with a pre-existing type 1 or type 2 diabetes diagnosis as well as those who developed gestational diabetes.
Read more
Type 1 Diabetes Testing News: Study Reveals Importance Of Support
The Royal College of Surgeons in Ireland released an interesting piece of news. It was done in conjunction with the University College Cork’s Sociology Department and focused on recent type 1 diabetes research. According to the Ireland-based healthcare professionals’ research, there are several factors that cause young people afflicted with type 1 diabetes (Type 1 Diabetes Test) to become stressed. They also found that those factors may be mitigated by providing type 1 diabetes sufferers with access to clinical and social support as well as educational materials.
Read more
Type 1 Diabetes Testing And ER Have Some People Feeling Hopeful
According to the International Diabetes Foundation’s figures, more than 380 million people around the world are coping with a diabetes diagnosis. That’s a lot of people that must alter their way of living and use Diabetes (type 1) testing supplies. However, if the researchers at the Harvard School of Public Health are correct, that number may drop in the future.
In December 2013, researchers connected with the school’s Hotamisligil Laboratory released the results of a study that revealed a potential way to prevent the disease from occurring. The potential solution to the longstanding disease rests with our endoplasmic reticulum (ER). For those that are unfamiliar with ER, it is an organelle found in some human cells. There are two types. They are referred to as rough and smooth. The rough one aids in protein synthesis. In those with type 1 diabetes, those cells are not functioning properly.
What researchers discovered is that there is an amphiphilic bile acid that has the capability of offsetting that dysfunction in laboratory mice. As a result of that offsetting, the onset of diabetes(Type 1) may effectively be delayed or stopped altogether. Of course, additional research and diabetes testing(type 1) must be conducted in the coming years to determine whether or not the same results may be possible to obtain in humans.
Until then, those living with the disease must continue with their type 1 diabetes testing regimens and insulin injections to ensure their quality of life. At this time, failure to properly manage the disease often results in the development of assorted comorbidities. Those comorbidities include vision loss, kidney failure, strokes, heart attacks, and blood vessel disease.
Lancet Diabetes – Users May Eventually Have More Pain-Free Choices
If you are one of the many Americans faced with having to use lancets (Lancet Diabetes), you may be excited to learn that there could very well be alternatives available in the near future. Word of the potential alternative was released during the last World Diabetes Congress. Here’s a look at what the advancement is and how it may change diabetics’ lives:
The company making the announcement was Abbott Diabetes Care. The potential advancement is being touted as an ambulatory glucose profile device. It is currently undergoing a clinical trial period. So it is likely to remain unavailable until sometime in the future. Nonetheless, the results thus far have been encouraging.
Read more
Diabetics May Need To Switch Blood Glucose Monitors In The Weeks Ahead
Earlier this year, the U.S. Federal Drug Administration began ruminating over the idea of changing the way that blood glucose monitors are used and classified. Needless to say, it created quite a stir among members of the healthcare community. Many people supported portions of the non-binding guidelines and vehemently opposed others. So what’s all the controversy about?
Read more
This Summer, Dont Forget To Take Along Your Diabetes Testing Supplies.
Being diabetic in our day and age is no longer life-altering. But the constant need to always have your Diabetes Testing Supplies can complicate your life. The constant need to prick your finger, check your levels, and watch what you eat can sometimes be enough to ruin a nice day out.
Read more
Things To Consider When Choosing The Right Glucose Meter
Research has shown that the key to reducing or avoiding diabetic complications is keeping the blood sugar tightly controlled; glucose meters are the main tool used to accomplish this. Currently there are about 75 different meters available in the United States with prices ranging from less than $10 to about $75. But take note: the price of the glucose meter does not necessarily reflect its quality or accuracy.
Read more
Type 1 Diabetes Testing And Gluten Free Diets: Can They Work Together?
For years, people have been searching for solutions to the world’s type 1 diabetes problem. It has lead to all sorts of conjecture as to which combination of actions can prevent, slow down or stop the disease from impacting individual’s lives. The most recent combination to be discussed is type 1 diabetes testing and gluten free diets.
Read more
How To Know When It’s Time For A New Glucose Meter
Many glucose meters can last more than 10 years and still function normally. If you’ve had your glucose meter for a while, you may be wondering when you should consider replacing it. The key to knowing when it’s time for new equipment primarily lies with the accuracy of your machine. Even so, you may still want to consider investing in a new meter in order to take advantage of improved technology.
Read more
Type 1 Diabetes Testing: Research News Shatters Longstanding Belief
The week of October 10, 2013, the periodical Diabetologia published the surprising results of a study recently completed in the field of type 1 diabetes research. Once released, it quickly made headlines around the world. The noteworthy research was conducted by a series of professionals affiliated with the National Institute for Health Research Exeter Clinical […]